Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Taking methocarbamol (Robaxin) daily for months is generally not recommended, since this muscle relaxant is intended for short-term use of two to three weeks alongside rest and physical therapy for acute muscle spasm. Long-term daily use raises the risk of persistent drowsiness, dizziness, falls, blurred vision, liver enzyme changes, and interactions with alcohol, opioids, or other sedatives, and it may mask an underlying condition that needs different treatment. Risk varies with your dose, age, kidney and liver function, and other medications, so there are several important factors to consider before continuing or stopping, including how to taper safely and which warning signs mean you should seek care right away. See below to understand more.
If you are relying on a muscle relaxant month after month, the real question is what keeps causing the pain or spasm, and that answer shapes your next steps. Take a free, instant, online symptom check to organize your symptoms, see possible explanations, and learn what type of care to seek next.
Last reviewed for medical accuracy: 09/17/2026
Methocarbamol is a prescription muscle relaxant often used short-term to ease pain and stiffness from strains, sprains or other acute musculoskeletal conditions. Taking methocarbamol daily for months isn’t typically recommended, and long-term use may carry risks. Below, we review what methocarbamol does, its potential side effects, and considerations if you or someone you know is on prolonged therapy.
Methocarbamol works in the central nervous system (brain and spinal cord) to relax skeletal muscles. It’s most often prescribed:
The U.S. Food and Drug Administration (FDA) approved methocarbamol in 1967, but clinical trials have focused on short-term safety and effectiveness. There’s limited data on daily use beyond several weeks.
Central Nervous System (CNS) Effects
Gastrointestinal Symptoms
Hepatic (Liver) Concerns
Allergic Reactions & Blood Disorders
Tolerance & Diminishing Effectiveness
Interactions with Other Substances
If you’ve been on methocarbamol daily for months, ask your healthcare provider whether you can:
Even if you tolerate methocarbamol well, consider periodic check-ins to prevent complications:
If you develop any of the following, stop methocarbamol and speak to a doctor right away:
Not sure what’s causing your symptoms? Try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
This information is not a substitute for professional medical advice. If you experience anything that feels life-threatening or seriously affects your health, speak to a doctor immediately.
(References)
* Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, Wright G. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Eur J Clin Pharmacol. 1990;39(2):193-4. doi: 10.1007/BF00280060. PMID: 2253675.
* FEUER SG, ROSENBAUM I, BARANOWSKA H. Methocarbamol injectable in treatment of acute and chronic muscle spasm. N Y State J Med. 1962 Jun 15;62:1985-9. PMID: 13892660.
* Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004 Aug;28(2):140-75. doi: 10.1016/j.jpainsymman.2004.05.002. PMID: 15276195.
* See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70. PMID: 18711953.
* Anastasio JD, Sharp CR. Acute aldicarb toxicity in dogs: 15 cases (2001-2009). J Vet Emerg Crit Care (San Antonio). 2011 Jun;21(3):253-60. doi: 10.1111/j.1476-4431.2011.00613.x. Epub 2011 Feb 11. PMID: 21631711.
* Ban VS, Bhoja R, McDonagh DL. Multimodal analgesia for craniotomy. Curr Opin Anaesthesiol. 2019 Oct;32(5):592-599. doi: 10.1097/ACO.0000000000000766. PMID: 31306155.
* Dey S, Kopitnik NL, Vrooman BM. Alternatives to Opioids for Managing Pain. 2026 Jan. PMID: 34662057.
* Miano TA, Wang L, Leonard CE, Brensinger CM, Acton EK, Dawwas GK, Bilker WB, Soprano SE, Nguyen TPP, Woody G, Yu E, Neuman M, Li L, Hennessy S. Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection. Clin Pharmacol Ther. 2022 Nov;112(5):1120-1129. doi: 10.1002/cpt.2717. Epub 2022 Aug 20. PMID: 35881659; PMCID: PMC10015595.
* Chan E, Waggoner C, Boylan PM. Commentary: Is Polyethylene Glycol Toxicity From Intravenous Methocarbamol Fact or Fiction? J Pain Palliat Care Pharmacother. 2024 Jun;38(2):180-184. doi: 10.1080/15360288.2024.2345322. Epub 2024 May 8. PMID: 38718034.
* Kawasaki M, Snead E. Successful management of lisdexamfetamine intoxication in a dog despite complications of hypoglycemia and rhabdomyolysis. Can Vet J. 2025 Oct;66(10):1063-1070. Epub 2025 Oct 1. PMID: 41030426; PMCID: PMC12477745.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.